论文部分内容阅读
近年来随着抗菌药物和化疗药物等在临床上的广泛使用,药物性肝炎的发病率也有逐年增高的趋势。为观察凯西莱治疗药物性肝炎的疗效和安全性,我们于2002年始对此进行了观察,现予报道如下。1资料和方法1.1资料56例药物性肝炎的病人,均为2002~2006年我院感染科的住院病人。所有病例
In recent years, with the widespread use of antibacterial drugs and chemotherapy drugs in clinical, the incidence of drug-induced hepatitis has also increased year by year. To observe the efficacy and safety of Kesilai in the treatment of drug-induced hepatitis, we observed this in the beginning of 2002 and are reported as follows. 1 Materials and Methods 1.1 Materials 56 cases of patients with drug-induced hepatitis, are from 2002 to 2006 in our hospital Infectious Diseases inpatients. All cases